Movement Disorder Market

Movement Disorder Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026

Analysis of Movement Disorder market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Market Overview

Global movement disorder market is expected to represent a value of over US$ 1,000 Mn by the end of the forecast period. Movement disorder market is anticipated to register a CAGR of 11.1% during the years, 2017 to 2026.

Prevalence of the mental disorders has continued to remain high among the old aged population globally. Neurological diseases such as Huntington’s disease, Parkinson’s disease and multiple symptom atrophy (MSA) continues to propel demand for management of the movement disorders. Lack of production of brain chemical dopamine by the nerve cells in the brain leads to uncoordinated movements and mental disorders that impact the everyday activities of the persons.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

FDA Approval to Boost Sales of Medications

Medications and treatments approved by FDA is also expected to impact growth of the global movement disorder market. Xadago (safinamide) tablets and Ingrezza capsules are two drugs that have recently cleared the FDA pipeline. Ingrezza capsules have recently received approval for treatment of dyskinesia and Xadago (safinamide) tablets have received approval of Parkinson’s disease.

In addition, the FDA has also approved implantation of brain to reduce the tremor symptoms. These factors are further expected to boost growth of the global movement disorders market.

Advanced Features to Impact Growth of the Global Market

In order to gain a competitive edge, various companies operating in the global movement disorder market are focusing on product innovation and developments. Manufacturers are mainly concentrating on incorporating advanced technology in the medical devices for faster recovery and improved results.

Equipped with the advanced features such as sensors, 360-degree stabilizing solutions and cloud technology. Parkinson’s spoon equipped with advanced technological features enable the end users to retrieve and store information regarding the status of the unwanted tremors and generates the algorithm of tremor patterns for optimal stabilization.

Moreover, the manufacturers operating in the global market are offering the electronic stabilizing handle, which comprises everyday spoon, spork, soup spoon and a fork. Bound to these factors, the global movement disorders market is expected to witness significant growth during the forecast period.

On the other hand, various factors continue to impact growth of the global movement disorders market negatively. Lack of investment in research and development will continue to inhibit growth of the global movement disorder market.

In addition, slow approval of the medications developed is further likely to impact growth of the global market negatively. Moreover, poor method of therapeutics conducted continues to pose significant challenges towards growth of the global market.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Parkinson ’s disease to Represent a Leading Segment

Growing need for medical devices with the uninterrupted functioning for treatment of the neurological disorders has led to an upsurge in adoption of rechargeable deep brain stimulator devices.

On the basis of product type, the rechargeable deep brain stimulator devices segment is expected to generate significant revenues, accounting for a value of over US$ 500 Mn by the end of 2026. However, the non-rechargeable deep brain stimulator devices product type segment is expected to register the highest CAGR during the forecast period.

Based on end user, the hospitals segment is expected to represent the highest revenue growth, recording a value of less than US$ 100 Mn by the end of 2017. On the other hand, the clinics end user segment is expected to register a robust through 2026.

By application, the Parkinson’s disease segment is expected to represent a significant revenue growth, accounting for a value of over US$ 400 Mn by the end of 2026. In contrary to this, the dystonia application segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating in the global movement disorder market include

  • Medtronic Plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Mayo Clinic

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Market Taxonomy

  • By Region:

    • North America
    • Latin America
    • Europe
    • Japan
    • APEJ
    • MEA

  • By Product Type:

    • Rechargeable Deep Brain Stimulator Devices
    • Non-rechargeable Deep Brain Stimulator Devices

  • By End User:

    • Hospitals
    • Ambulatory Surgical Centers
    • Clinics

  • By Application Type:

    • Parkinson's Disease
    • Essential Tremor
    • Dystonia
    • Refractory Epilepsy
    • Obsessive Compulsive Disorder

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Inability to generate movements affects the functioning of nerves, brain and the spinal cord adversely. Neurological disorders has led to surge in diseases such as trauma, convulsive diseases, cerebrovascular diseases, brain tumors and degenerative diseases.

Growing prevalence of such mental disorders impact the cognitive abilities and lead to increasing prevalence of insomnia, depression, swallowing, inability to chew and speaking.

Surge in awareness attributed to increasing prevalence of the neurological diseases is expected to impact growth of the global movement disorders market positively.

Table of Content

  • 1. Global Outlook
  • 2. Global Market - Executive Summary
  • 3. Global Market Overview
  • 4. Global Market Analysis and Forecast 2012 to 2026
    • 4.1 Global Market Size and Forecast by Product Type, 2012 to 2026
      • 4.1.1 Rechargeable Deep Brain Stimulator Devices
      • 4.1.2 Non-rechargeable Deep Brain Stimulator Devices
    • 4.2 Global Market Size and Forecast by End User, 2012 to 2026
      • 4.2.1 Hospitals
      • 4.2.2 Ambulatory Surgical Centers
      • 4.2.3 Clinics
    • 4.3 Global Market Size and Forecast by Application Type, 2012 to 2026
      • 4.3.1 Parkinson's Disease
      • 4.3.2 Essential Tremor
      • 4.3.3 Dystonia
      • 4.3.4 Refractory Epilepsy
      • 4.3.5 Obsessive Compulsive Disorder
  • 5. North America Market Size and Forecast, 2012 to 2026
  • 6. Latin America Market Size and Forecast, 2012 to 2026
  • 7. Europe Market Size and Forecast, 2012 to 2026
  • 8. Japan Market Size and Forecast, 2012 to 2026
  • 9. APEJ Market Size and Forecast, 2012 to 2026
  • 10. MEA Market Size and Forecast, 2012 to 2026
  • 11. Global Market – Competitive Landscape and Company Profiles
    • 11.1 Medtronic Plc
    • 11.2 Abbott Laboratories Inc
    • 11.3 Boston Scientific Corporation
    • 11.4 Mayo Clinic
  • 12. Fact.MR Research Methodology
  • 13. Disclaimer

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

TABLE 1 Global Market Value (US$ Mn), 2012 to 2017

TABLE 2 Global Market Value (US$ Mn), 2018 to 2026

TABLE 3 Global Market Value (US$ Mn) and Y-o-Y, 2017 to 2026

TABLE 4 Global Rechargeable Deep Brain Stimulator Devices Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 5 Global Rechargeable Deep Brain Stimulator Devices Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 6 Global Rechargeable Deep Brain Stimulator Devices Segment Market Share, By Region 2012 to 2017

TABLE 7 Global Rechargeable Deep Brain Stimulator Devices Segment Market Share, By Region 2018 to 2026

TABLE 8 Global Rechargeable Deep Brain Stimulator Devices Segment Y-o-Y, By Region 2017 to 2026

TABLE 9 Global Non-rechargeable Deep Brain Stimulator Devices Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 10 Global Non-rechargeable Deep Brain Stimulator Devices Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 11 Global Non-rechargeable Deep Brain Stimulator Devices Segment Market Share, By Region 2012 to 2017

TABLE 12 Global Non-rechargeable Deep Brain Stimulator Devices Segment Market Share, By Region 2018 to 2026

TABLE 13 Global Non-rechargeable Deep Brain Stimulator Devices Segment Y-o-Y, By Region 2017 to 2026

TABLE 14 Global Hospitals Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 15 Global Hospitals Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 16 Global Hospitals Segment Market Share, By Region 2012 to 2017

TABLE 17 Global Hospitals Segment Market Share, By Region 2018 to 2026

TABLE 18 Global Hospitals Segment Y-o-Y, By Region 2017 to 2026

TABLE 19 Global Ambulatory Surgical Centers Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 20 Global Ambulatory Surgical Centers Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 21 Global Ambulatory Surgical Centers Segment Market Share, By Region 2012 to 2017

TABLE 22 Global Ambulatory Surgical Centers Segment Market Share, By Region 2018 to 2026

TABLE 23 Global Ambulatory Surgical Centers Segment Y-o-Y, By Region 2017 to 2026

TABLE 24 Global Clinics Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 25 Global Clinics Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 26 Global Clinics Segment Market Share, By Region 2012 to 2017

TABLE 27 Global Clinics Segment Market Share, By Region 2018 to 2026

TABLE 28 Global Clinics Segment Y-o-Y, By Region 2017 to 2026

TABLE 29 Global Parkinson's Disease Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 30 Global Parkinson's Disease Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 31 Global Parkinson's Disease Segment Market Share, By Region 2012 to 2017

TABLE 32 Global Parkinson's Disease Segment Market Share, By Region 2018 to 2026

TABLE 33 Global Parkinson's Disease Segment Y-o-Y, By Region 2017 to 2026

TABLE 34 Global Essential Tremor Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 35 Global Essential Tremor Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 36 Global Essential Tremor Segment Market Share, By Region 2012 to 2017

TABLE 37 Global Essential Tremor Segment Market Share, By Region 2018 to 2026

TABLE 38 Global Essential Tremor Segment Y-o-Y, By Region 2017 to 2026

TABLE 39 Global Dystonia Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 40 Global Dystonia Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 41 Global Dystonia Segment Market Share, By Region 2012 to 2017

TABLE 42 Global Dystonia Segment Market Share, By Region 2018 to 2026

TABLE 43 Global Dystonia Segment Y-o-Y, By Region 2017 to 2026

TABLE 44 Global Refractory Epilepsy Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 45 Global Refractory Epilepsy Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 46 Global Refractory Epilepsy Segment Market Share, By Region 2012 to 2017

TABLE 47 Global Refractory Epilepsy Segment Market Share, By Region 2018 to 2026

TABLE 48 Global Refractory Epilepsy Segment Y-o-Y, By Region 2017 to 2026

TABLE 49 Global Obsessive Compulsive Disorder Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 50 Global Obsessive Compulsive Disorder Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 51 Global Obsessive Compulsive Disorder Segment Market Share, By Region 2012 to 2017

TABLE 52 Global Obsessive Compulsive Disorder Segment Market Share, By Region 2018 to 2026

TABLE 53 Global Obsessive Compulsive Disorder Segment Y-o-Y, By Region 2017 to 2026

TABLE 54 North America Current Expenditure on Health, (% of GDP), by Country, 2010 to 2016

TABLE 55 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 to 2016

TABLE 56 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 to 2016

TABLE 57 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 to 2016

TABLE 58 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 to 2016

TABLE 59 North America Market Value (US$ Mn), By Country 2012 to 2017

TABLE 60 North America Market Value (US$ Mn), By Country 2018 to 2026

TABLE 61 North America Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 62 North America Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 63 North America Market Value (US$ Mn), By End User2012 to 2017

TABLE 64 North America Market Value (US$ Mn), By End User2018 to 2026

TABLE 65 North America Market Value (US$ Mn), By Application Type2012 to 2017

TABLE 66 North America Market Value (US$ Mn), By Application Type2018 to 2026

TABLE 67 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 to 2016

TABLE 68 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 to 2016

TABLE 69 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 to 2016

TABLE 70 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 to 2016

TABLE 71 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 to 2016

TABLE 72 Latin America Market Value (US$ Mn), By Country 2012 to 2017

TABLE 73 Latin America Market Value (US$ Mn), By Country 2018 to 2026

TABLE 74 Latin America Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 75 Latin America Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 76 Latin America Market Value (US$ Mn), By End User2012 to 2017

TABLE 77 Latin America Market Value (US$ Mn), By End User2018 to 2026

TABLE 78 Latin America Market Value (US$ Mn), By Application Type2012 to 2017

TABLE 79 Latin America Market Value (US$ Mn), By Application Type2018 to 2026

TABLE 80 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 to 2016

TABLE 81 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 to 2016

TABLE 82 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 to 2016

TABLE 83 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 to 2016

TABLE 84 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 to 2016

TABLE 85 Europe Market Value (US$ Mn), By Country 2012 to 2017

TABLE 86 Europe Market Value (US$ Mn), By Country 2018 to 2026

TABLE 87 Europe Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 88 Europe Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 89 Europe Market Value (US$ Mn), By End User2012 to 2017

TABLE 90 Europe Market Value (US$ Mn), By End User2018 to 2026

TABLE 91 Europe Market Value (US$ Mn), By Application Type2012 to 2017

TABLE 92 Europe Market Value (US$ Mn), By Application Type2018 to 2026

TABLE 93 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 to 2016

TABLE 94 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 to 2016

TABLE 95 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 to 2016

TABLE 96 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 to 2016

TABLE 97 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 to 2016

TABLE 98 Japan Market Value (US$ Mn), By Country 2012 to 2017

TABLE 99 Japan Market Value (US$ Mn), By Country 2018 to 2026

TABLE 100 Japan Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 101 Japan Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 102 Japan Market Value (US$ Mn), By End User2012 to 2017

TABLE 103 Japan Market Value (US$ Mn), By End User2018 to 2026

TABLE 104 Japan Market Value (US$ Mn), By Application Type2012 to 2017

TABLE 105 Japan Market Value (US$ Mn), By Application Type2018 to 2026

TABLE 106 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 to 2016

TABLE 107 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 to 2016

TABLE 108 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 to 2016

TABLE 109 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 to 2016

TABLE 110 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 to 2016

TABLE 111 APEJ Market Value (US$ Mn), By Country 2012 to 2017

TABLE 112 APEJ Market Value (US$ Mn), By Country 2018 to 2026

TABLE 113 APEJ Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 114 APEJ Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 115 APEJ Market Value (US$ Mn), By End User2012 to 2017

TABLE 116 APEJ Market Value (US$ Mn), By End User2018 to 2026

TABLE 117 APEJ Market Value (US$ Mn), By Application Type2012 to 2017

TABLE 118 APEJ Market Value (US$ Mn), By Application Type2018 to 2026

TABLE 119 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 to 2016

TABLE 120 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 to 2016

TABLE 121 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 to 2016

TABLE 122 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 to 2016

TABLE 123 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 to 2016

TABLE 124 MEA Market Value (US$ Mn), By Country 2012 to 2017

TABLE 125 MEA Market Value (US$ Mn), By Country 2018 to 2026

TABLE 126 MEA Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 127 MEA Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 128 MEA Market Value (US$ Mn), By End User2012 to 2017

TABLE 129 MEA Market Value (US$ Mn), By End User2018 to 2026

TABLE 130 MEA Market Value (US$ Mn), By Application Type2012 to 2017

TABLE 131 MEA Market Value (US$ Mn), By Application Type2018 to 2026

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

FIG. 1 Global Market Market Value (US$ Mn), 2012 to 2017

FIG. 2 Global Market Market Value (US$ Mn) Forecast, 2018 to 2026

FIG. 3 Global Market Market Value (US$ Mn) and Y-o-Y, 2017 to 2026

FIG. 4 Global Rechargeable Deep Brain Stimulator Devices Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 5 Global Rechargeable Deep Brain Stimulator Devices Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 6 Global Rechargeable Deep Brain Stimulator Devices Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 7 Global Non-rechargeable Deep Brain Stimulator Devices Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 8 Global Non-rechargeable Deep Brain Stimulator Devices Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 9 Global Non-rechargeable Deep Brain Stimulator Devices Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 10 Global Hospitals Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 11 Global Hospitals Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 12 Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 13 Global Ambulatory Surgical Centers Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 14 Global Ambulatory Surgical Centers Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 15 Global Ambulatory Surgical Centers Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 16 Global Clinics Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 17 Global Clinics Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 18 Global Clinics Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 19 Global Parkinson's Disease Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 20 Global Parkinson's Disease Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 21 Global Parkinson's Disease Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 22 Global Essential Tremor Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 23 Global Essential Tremor Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 24 Global Essential Tremor Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 25 Global Dystonia Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 26 Global Dystonia Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 27 Global Dystonia Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 28 Global Refractory Epilepsy Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 29 Global Refractory Epilepsy Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 30 Global Refractory Epilepsy Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 31 Global Obsessive Compulsive Disorder Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 32 Global Obsessive Compulsive Disorder Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 33 Global Obsessive Compulsive Disorder Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 34 North America Market Market Value (US$ Mn), By Country 2012 to 2017

FIG. 35 North America Market Market Value (US$ Mn), By Country 2018 to 2026

FIG. 36 North America Market Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 37 North America Market Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 38 North America Market Market Value (US$ Mn), By End User 2012 to 2017

FIG. 39 North America Market Market Value (US$ Mn), By End User 2018 to 2026

FIG. 40 North America Market Market Value (US$ Mn), By Application Type 2012 to 2017

FIG. 41 North America Market Market Value (US$ Mn), By Application Type 2018 to 2026

FIG. 42 Latin America Market Market Value (US$ Mn), By Country 2012 to 2017

FIG. 43 Latin America Market Market Value (US$ Mn), By Country 2018 to 2026

FIG. 44 Latin America Market Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 45 Latin America Market Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 46 Latin America Market Market Value (US$ Mn), By End User 2012 to 2017

FIG. 47 Latin America Market Market Value (US$ Mn), By End User 2018 to 2026

FIG. 48 Latin America Market Market Value (US$ Mn), By Application Type 2012 to 2017

FIG. 49 Latin America Market Market Value (US$ Mn), By Application Type 2018 to 2026

FIG. 50 Europe Market Market Value (US$ Mn), By Country 2012 to 2017

FIG. 51 Europe Market Market Value (US$ Mn), By Country 2018 to 2026

FIG. 52 Europe Market Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 53 Europe Market Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 54 Europe Market Market Value (US$ Mn), By End User 2012 to 2017

FIG. 55 Europe Market Market Value (US$ Mn), By End User 2018 to 2026

FIG. 56 Europe Market Market Value (US$ Mn), By Application Type 2012 to 2017

FIG. 57 Europe Market Market Value (US$ Mn), By Application Type 2018 to 2026

FIG. 58 Japan Market Market Value (US$ Mn), By Country 2012 to 2017

FIG. 59 Japan Market Market Value (US$ Mn), By Country 2018 to 2026

FIG. 60 Japan Market Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 61 Japan Market Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 62 Japan Market Market Value (US$ Mn), By Application Type 2012 to 2017

FIG. 63 Japan Market Market Value (US$ Mn), By End User2018 to 2026

FIG. 64 Japan Market Market Value (US$ Mn), By Application Type 2012 to 2017

FIG. 65 Japan Market Market Value (US$ Mn), By Application Type 2018 to 2026

FIG. 66 APEJ Market Market Value (US$ Mn), By Country 2012 to 2017

FIG. 67 APEJ Market Market Value (US$ Mn), By Country 2018 to 2026

FIG. 68 APEJ Market Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 69 APEJ Market Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 70 APEJ Market Market Value (US$ Mn), By End User 2012 to 2017

FIG. 71 APEJ Market Market Value (US$ Mn), By End User 2018 to 2026

FIG. 72 APEJ Market Market Value (US$ Mn), By Application Type 2012 to 2017

FIG. 73 APEJ Market Market Value (US$ Mn), By Application Type 2018 to 2026

FIG. 74 MEA Market Market Value (US$ Mn), By Country 2012 to 2017

FIG. 75 MEA Market Market Value (US$ Mn), By Country 2018 to 2026

FIG. 76 MEA Market Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 77 MEA Market Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 78 MEA Market Market Value (US$ Mn), By End User2012 to 2017

FIG. 79 MEA Market Market Value (US$ Mn), By End User2018 to 2026

FIG. 80 MEA Market Market Value (US$ Mn), By Application Type 2012 to 2017

FIG. 81 MEA Market Market Value (US$ Mn), By Application Type 2018 to 2026

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

How much is the Movement Disorder market like to be valued by 2026?

The Movement Disorder market is expected to reach nearly US$ 1,000 Mn by 2026

Who are the prominent Movement Disorder market players?

Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Mayo Clinic are prominent Movement Disorder market players.

Movement Disorder Market

Schedule a Call

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services